Fundamental Analysis of KINETA INC(NASDAQ:KA) stock

Fundamental Rating

KA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 587 industry peers in the Biotechnology industry. KA may be in some trouble as it scores bad on both profitability and health. KA has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

KA had negative earnings in the past year.

KA had a negative operating cash flow in the past year.

In the past 5 years KA always reported negative net income.

In the past 5 years KA always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of KA (-137.09%) is worse than 84.79% of its industry peers.

The Return On Equity of KA (-487.68%) is worse than 79.83% of its industry peers.

		Industry Rank	Sector Rank
ROA	-137.09%
ROE	-487.68%
ROIC	N/A

ROA(3y)-188.12%

ROA(5y)-135.68%

ROE(3y)-699.02%

ROE(5y)-456.44%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for KA so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

KA does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for KA has been increased compared to 1 year ago.

KA has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, KA has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -26.68, we must say that KA is in the distress zone and has some risk of bankruptcy.

Looking at the Altman-Z score, with a value of -26.68, KA is doing worse than 90.26% of the companies in the same industry.

A Debt/Equity ratio of 0.05 indicates that KA is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.05, KA is doing worse than 60.68% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF	N/A
Altman-Z	-26.68

ROIC/WACCN/A

WACC8.56%

2.3 Liquidity

KA has a Current Ratio of 0.85. This is a bad value and indicates that KA is not financially healthy enough and could expect problems in meeting its short term obligations.

With a Current ratio value of 0.85, KA is not doing good in the industry: 90.77% of the companies in the same industry are doing better.

KA has a Quick Ratio of 0.85. This is a bad value and indicates that KA is not financially healthy enough and could expect problems in meeting its short term obligations.

The Quick ratio of KA (0.85) is worse than 90.09% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.85
Quick Ratio	0.85

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

KA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.45%, which is quite impressive.

Looking at the last year, KA shows a very strong growth in Revenue. The Revenue has grown by 178.97%.

KA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.89% yearly.

EPS 1Y (TTM)91.45%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q91.27%

Revenue 1Y (TTM)178.97%

Revenue growth 3Y-7.61%

Revenue growth 5Y13.89%

Revenue growth Q2Q100%

3.2 Future

KA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.59% yearly.

KA is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -41.42% yearly.

EPS Next Y20.69%

EPS Next 2Y3.59%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-89.27%

Revenue Next 2Y-41.42%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for KA. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for KA. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y3.59%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for KA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

KINETA INC

NASDAQ:KA (5/6/2024, 3:07:46 PM)

0.582

-0.01 (-1.34%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap6.61M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-137.09%
ROE	-487.68%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.53

Health

		Industry Rank	Sector Rank
Debt/Equity	0.05
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	0.85
Quick Ratio	0.85
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)91.45%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y20.69%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)178.97%

Revenue growth 3Y-7.61%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

KINETA INC (KA)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens